Ritonavir is Used for treating HIV infection in combination with other antiretroviral agents. It was first introduced by Abbvie Inc in its drug Norvir on Mar 1, 1996. 8 different companies have introduced drugs containing Ritonavir.

Ritonavir Patents

Given below is the list of patents protecting Ritonavir, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Norvir	US8470347 (Pediatric)	Self-emulsifying active substance formulation and use of this formulation	Mar 17, 2027	Abbvie
Norvir	US8470347	Self-emulsifying active substance formulation and use of this formulation	Sep 17, 2026	Abbvie
Norvir	US8268349 (Pediatric)	Solid pharmaceutical dosage form	Feb 25, 2025 (Expired)	Abbvie
Norvir	US8399015 (Pediatric)	Solid pharmaceutical dosage form	Feb 25, 2025 (Expired)	Abbvie
Norvir	US8691878 (Pediatric)	Solid pharmaceutical dosage form	Feb 25, 2025 (Expired)	Abbvie
Norvir	US8268349	Solid pharmaceutical dosage form	Aug 25, 2024 (Expired)	Abbvie
Norvir	US8399015	Solid pharmaceutical dosage form	Aug 25, 2024 (Expired)	Abbvie
Norvir	US8691878	Solid pharmaceutical dosage form	Aug 25, 2024 (Expired)	Abbvie
Norvir	US7364752 (Pediatric)	Solid dispersion pharamaceutical formulations	May 10, 2021 (Expired)	Abbvie
Norvir	US7141593 (Pediatric)	Pharmaceutical formulations	Nov 22, 2020 (Expired)	Abbvie
Norvir	US7432294 (Pediatric)	Pharmaceutical formulations	Nov 22, 2020 (Expired)	Abbvie
Norvir	US7364752	Solid dispersion pharamaceutical formulations	Nov 10, 2020 (Expired)	Abbvie
Norvir	US7141593	Pharmaceutical formulations	May 22, 2020 (Expired)	Abbvie
Norvir	US7432294	Pharmaceutical formulations	May 22, 2020 (Expired)	Abbvie
Norvir	US7148359 (Pediatric)	Polymorph of a pharmaceutical	Jan 19, 2020 (Expired)	Abbvie
Norvir	US7148359	Polymorph of a pharmaceutical	Jul 19, 2019 (Expired)	Abbvie
Norvir	US6232333 (Pediatric)	Pharmaceutical composition	May 07, 2018 (Expired)	Abbvie
Norvir	US6232333	Pharmaceutical composition	Nov 07, 2017 (Expired)	Abbvie
Norvir	US6037157 (Pediatric)	Method for improving pharmacokinetics	Dec 26, 2016 (Expired)	Abbvie
Norvir	US6703403 (Pediatric)	Method for improving pharmacokinetics	Dec 26, 2016 (Expired)	Abbvie
Norvir	US6037157	Method for improving pharmacokinetics	Jun 26, 2016 (Expired)	Abbvie
Norvir	US6703403	Method for improving pharmacokinetics	Jun 26, 2016 (Expired)	Abbvie
Norvir	US5648497 (Pediatric)	Retroviral protease inhibiting compounds	Jan 15, 2015 (Expired)	Abbott
Norvir	US5648497 (Pediatric)	Retroviral protease inhibiting compounds	Jan 15, 2015 (Expired)	Abbvie
Norvir	US5635523 (Pediatric)	Retroviral protease inhibiting compounds	Dec 03, 2014 (Expired)	Abbott
Norvir	US5484801 (Pediatric)	Pharmaceutical composition for inhibiting HIV protease	Jul 28, 2014 (Expired)	Abbvie
Norvir	US5648497	Retroviral protease inhibiting compounds	Jul 15, 2014 (Expired)	Abbott
Norvir	US5648497	Retroviral protease inhibiting compounds	Jul 15, 2014 (Expired)	Abbvie
Norvir	US5635523	Retroviral protease inhibiting compounds	Jun 03, 2014 (Expired)	Abbott
Norvir	US5948436 (Pediatric)	Pharmaceutical composition	Mar 13, 2014 (Expired)	Abbott
Norvir	US5948436 (Pediatric)	Pharmaceutical composition	Mar 13, 2014 (Expired)	Abbvie
Norvir	US5541206 (Pediatric)	Retroviral protease inhibiting compounds	Jan 30, 2014 (Expired)	Abbott
Norvir	US5541206 (Pediatric)	Retroviral protease inhibiting compounds	Jan 30, 2014 (Expired)	Abbvie
Norvir	US5635523 (Pediatric)	Retroviral protease inhibiting compounds	Jan 30, 2014 (Expired)	Abbvie
Norvir	US5674882 (Pediatric)	Retroviral protease inhibiting compounds	Jan 30, 2014 (Expired)	Abbvie
Norvir	US5484801	Pharmaceutical composition for inhibiting HIV protease	Jan 28, 2014 (Expired)	Abbvie
Norvir	US5948436	Pharmaceutical composition	Sep 13, 2013 (Expired)	Abbott
Norvir	US5948436	Pharmaceutical composition	Sep 13, 2013 (Expired)	Abbvie
Norvir	US5541206	Retroviral protease inhibiting compounds	Jul 30, 2013 (Expired)	Abbott
Norvir	US5541206	Retroviral protease inhibiting compounds	Jul 30, 2013 (Expired)	Abbvie
Norvir	US5635523	Retroviral protease inhibiting compounds	Jul 30, 2013 (Expired)	Abbvie
Norvir	US5674882	Retroviral protease inhibiting compounds	Jul 30, 2013 (Expired)	Abbvie

Add above patents to watchlist

Ritonavir's Family Patents

Full family tree

Ritonavir Generic API Manufacturers

Several generic applications have been filed for Ritonavir. The first generic version for Ritonavir was by Cipla Ltd and was approved on Jan 15, 2015. And the latest generic version is by Norvium Bioscience Llc and was approved on Feb 16, 2024.

Given below is the list of companies who have filed for Ritonavir generic, along with the locations of their manufacturing plants worldwide.